Marsh & McLennan Companies, Inc. $MRSH Shares Bought by Kinsale Capital Group Inc.

Kinsale Capital Group Inc. increased its holdings in Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 25.1% during the third quarter, Holdings Channel.com reports. The firm owned 71,927 shares of the financial services provider’s stock after acquiring an additional 14,447 shares during the quarter. Marsh & McLennan Companies accounts for 1.6% of Kinsale Capital Group Inc.’s investment portfolio, making the stock its 23rd largest holding. Kinsale Capital Group Inc.’s holdings in Marsh & McLennan Companies were worth $12,280,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Asset Dedication LLC bought a new position in shares of Marsh & McLennan Companies during the first quarter valued at about $25,000. Quest 10 Wealth Builders Inc. increased its holdings in shares of Marsh & McLennan Companies by 95.0% in the third quarter. Quest 10 Wealth Builders Inc. now owns 156 shares of the financial services provider’s stock worth $27,000 after buying an additional 76 shares during the period. EFG International AG bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc bought a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $31,000. Finally, Trifecta Capital Advisors LLC purchased a new stake in Marsh & McLennan Companies during the 2nd quarter valued at about $34,000. 87.99% of the stock is owned by institutional investors.

Marsh & McLennan Companies Trading Down 0.1%

MRSH stock opened at $204.59 on Tuesday. The stock has a market capitalization of $97.29 billion, a PE ratio of 24.47, a price-to-earnings-growth ratio of 2.84 and a beta of 0.53. The company has a 50-day moving average price of $184.01. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.09 and a quick ratio of 1.09. Marsh & McLennan Companies, Inc. has a 12-month low of $156.60 and a 12-month high of $214.00.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.96 by $0.07. The company had revenue of $6.86 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.20% and a return on equity of 33.32%. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. Equities analysts predict that Marsh & McLennan Companies, Inc. will post 10.49 EPS for the current year.

Marsh & McLennan Companies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.99 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a yield of 1.9%. Marsh & McLennan Companies’s dividend payout ratio is presently 47.37%.

Insider Buying and Selling

In other news, CEO Dean Klisura sold 4,194 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $200.00, for a total transaction of $838,800.00. Following the transaction, the chief executive officer directly owned 20,935 shares of the company’s stock, valued at approximately $4,187,000. The trade was a 16.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Stacy Mills sold 1,215 shares of the business’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $200.00, for a total value of $243,000.00. Following the transaction, the vice president directly owned 2,705 shares in the company, valued at $541,000. This trade represents a 30.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MRSH shares. Weiss Ratings restated a “hold (c)” rating on shares of Marsh & McLennan Companies in a research report on Wednesday, November 4th. Morgan Stanley lowered their price objective on Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating for the company in a research report on Tuesday, October 6th. Wells Fargo & Company increased their price objective on Marsh & McLennan Companies from $183.00 to $197.00 and gave the company an “equal weight” rating in a research note on Friday, October 16th. Evercore dropped their price objective on Marsh & McLennan Companies from $234.00 to $224.00 in a research note on Thursday, October 8th. Finally, BMO Capital Markets upgraded shares of Marsh & McLennan Companies from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $204.00 to $230.00 in a report on Tuesday, November 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $205.84.

About Marsh & McLennan Companies

Marsh & McLennan Companies, now known as Marsh, is a professional services firm focused on risk, strategy and people. Its businesses help organizations assess and manage risk, arrange insurance and reinsurance, and address workforce and organizational challenges.

The company operates through Marsh, an insurance brokerage and risk advisory business; Guy Carpenter, which specializes in reinsurance and related risk services; Mercer, which provides health, wealth and career consulting; and Oliver Wyman, a management consulting firm.